Treatment of malaria in Austria: Hazardous for patients or physicians?

Wiener Klinische Wochenschrift

Volumn 121, Issue 17-18, 2009, Pages 598-

  Ramharter, Michael ^a   Bélard, Sabine ^b   Kurth, Florian ^b   Winkler, Stefan ^b   Graninger, Wolfgang ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTESUNATE; QUININE;

AUSTRIA; CHINESE MEDICINE; HUMAN; LETTER; MALARIA FALCIPARUM; SELF MEDICATION; TRAVEL;

ANTI-INFECTIVE AGENTS; ARTEMISININS; DRUG APPROVAL; HUMANS; MALARIA;

EID: 70450206765     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-009-1239-y     Document Type: Letter

References (5)

1. PG Kremsner S Krishna 2004 Antimalarial combinations Lancet 364 9430 285 294 10.1016/S0140-6736(04)16680-4 1:CAS:528:DC%2BD2cXlslyrt74%3D 15262108 (Pubitemid 38942820)
2. A Dondorp F Nosten K Stepniewska N Day N White South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group 2005 Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial Lancet 366 9487 717 725 10.1016/S0140-6736(05)67176-0 16125588 (Pubitemid 41207233)
3. World Health Organization (2006) Guidelines for the treatment of malaria. Geneva 2006
4. Centers for Disease Control and Prevention. Accessed on 26th May 2009 at: www.cdc.gov/Malaria/diagnosis-treatment/tx-clinicians.htm
5. T Jelinek 2005 Intravenous artesunate recommended for patients with severe malaria: position statement from TropNetEurop Euro Surveill 10 11 E051124.5 16794288